Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis.

Bombard Y, Miller FA, Barg CJ, Patton SJ, Carroll JC, Chakraborty P, Potter BK, Tam K, Taylor L, Kerr E, Davies C, Milburn J, Ratjen F, Guttmann A, Hayeems RZ.

Genet Med. 2016 Sep 8. doi: 10.1038/gim.2016.125. [Epub ahead of print]

PMID:
27608173
2.

Changing incidence of cystic fibrosis in Wisconsin, USA.

Parker-McGill K, Nugent M, Bersie R, Hoffman G, Rock M, Baker M, Farrell PM, Simpson P, Levy H.

Pediatr Pulmonol. 2015 Nov;50(11):1065-72. doi: 10.1002/ppul.23265. Epub 2015 Aug 10.

3.

Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening.

Ulph F, Cullinan T, Qureshi N, Kai J.

Eur J Hum Genet. 2015 Apr;23(4):459-65. doi: 10.1038/ejhg.2014.126. Epub 2014 Jul 9.

4.

Genetic data and electronic health records: a discussion of ethical, logistical and technological considerations.

Shoenbill K, Fost N, Tachinardi U, Mendonca EA.

J Am Med Inform Assoc. 2014 Jan-Feb;21(1):171-80. doi: 10.1136/amiajnl-2013-001694. Epub 2013 Jun 14. Review.

5.

Assessing the Disease-Liability of Mutations in CFTR.

Ferec C, Cutting GR.

Cold Spring Harb Perspect Med. 2012 Dec 1;2(12):a009480. doi: 10.1101/cshperspect.a009480.

6.

Frequency of high-quality communication behaviors used by primary care providers of heterozygous infants after newborn screening.

Farrell MH, Christopher SA.

Patient Educ Couns. 2013 Feb;90(2):226-32. doi: 10.1016/j.pec.2012.10.024. Epub 2012 Nov 26.

7.

Reply to Ross' commentary: Reproductive benefit through newborn screening: preferences, policy and ethics.

Bombard Y, Miller FA.

Eur J Hum Genet. 2012 May;20(5):486-7. doi: 10.1038/ejhg.2012.25. Epub 2012 Feb 29. No abstract available.

8.

Factors that influence parents' experiences with results disclosure after newborn screening identifies genetic carrier status for cystic fibrosis or sickle cell hemoglobinopathy.

Collins JL, La Pean A, O'Tool F, Eskra KL, Roedl SJ, Tluczek A, Farrell MH.

Patient Educ Couns. 2013 Mar;90(3):378-85. doi: 10.1016/j.pec.2011.12.007. Epub 2012 Jan 11.

9.

Newborn screening for sickle cell disease: whose reproductive benefit?

Ross LF.

Eur J Hum Genet. 2012 May;20(5):484-5. doi: 10.1038/ejhg.2011.191. Epub 2011 Nov 9. No abstract available.

10.

Psychosocial consequences of false-positive newborn screens for cystic fibrosis.

Tluczek A, Orland KM, Cavanagh L.

Qual Health Res. 2011 Feb;21(2):174-86. doi: 10.1177/1049732310382919. Epub 2010 Sep 17.

11.

Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening.

McClaren BJ, Metcalfe SA, Aitken M, Massie RJ, Ukoumunne OC, Amor DJ.

Eur J Hum Genet. 2010 Oct;18(10):1084-9. doi: 10.1038/ejhg.2010.78. Epub 2010 May 26.

12.

Genetic testing in asymptomatic minors: background considerations towards ESHG Recommendations.

Borry P, Evers-Kiebooms G, Cornel MC, Clarke A, Dierickx K; Public and Professional Policy Committee (PPPC) of the European Society of Human Genetics (ESHG)..

Eur J Hum Genet. 2009 Jun;17(6):711-9. doi: 10.1038/ejhg.2009.25. Epub 2009 Mar 11.

13.

Questioning the consensus: managing carrier status results generated by newborn screening.

Miller FA, Robert JS, Hayeems RZ.

Am J Public Health. 2009 Feb;99(2):210-5. doi: 10.2105/AJPH.2008.136614. Epub 2008 Dec 4.

14.

Newborn screening for cystic fibrosis: a lesson in public health disparities.

Ross LF.

J Pediatr. 2008 Sep;153(3):308-13. doi: 10.1016/j.jpeds.2008.04.061. Review. No abstract available.

15.

Reproductive decisions after neonatal screening identifies cystic fibrosis.

Dudding T, Wilcken B, Burgess B, Hambly J, Turner G.

Arch Dis Child Fetal Neonatal Ed. 2000 Mar;82(2):F124-7.

16.

Early diagnosis of cystic fibrosis can improve children's growth.

Farrell PM.

BMJ. 1998 Oct 10;317(7164):1017. No abstract available.

Supplemental Content

Support Center